000 01429 a2200361 4500
005 20250518093329.0
264 0 _c20200911
008 202009s 0 0 eng d
022 _a1569-8041
024 7 _a10.1093/annonc/mdz384
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSolomon, J P
245 0 0 _aIdentifying patients with NTRK fusion cancer.
_h[electronic resource]
260 _bAnnals of oncology : official journal of the European Society for Medical Oncology
_c11 2019
300 _aviii16-viii22 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aBiomarkers, Tumor
_xgenetics
650 0 4 _aHigh-Throughput Nucleotide Sequencing
_xmethods
650 0 4 _aHumans
650 0 4 _aImmunohistochemistry
_xmethods
650 0 4 _aIn Situ Hybridization, Fluorescence
_xmethods
650 0 4 _aMembrane Glycoproteins
_xgenetics
650 0 4 _aNeoplasms
_xdiagnosis
650 0 4 _aOncogene Proteins, Fusion
_xgenetics
650 0 4 _aReceptor, trkA
_xgenetics
650 0 4 _aReceptor, trkB
_xgenetics
650 0 4 _aReceptor, trkC
_xgenetics
700 1 _aBenayed, R
700 1 _aHechtman, J F
700 1 _aLadanyi, M
773 0 _tAnnals of oncology : official journal of the European Society for Medical Oncology
_gvol. 30 Suppl 8
_gp. viii16-viii22
856 4 0 _uhttps://doi.org/10.1093/annonc/mdz384
_zAvailable from publisher's website
999 _c30791811
_d30791811